2023 Annual Meeting | P12 - Poster Session 12

Date Wednesday 04/26/23

Time 05:30 PM - 06:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Neuro-oncology, Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Education, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-rehabilitation

CME Available 0.00 CME credit

Event Timeline
05:30 PM - 06:30 PM EST	Abstract	9-001 - Auras in Persons with Focal and Generalized Epilepsy: Types and Patient Numbers from a Tertiary Level Epilepsy Center Fahham Asghar, MD
05:30 PM - 06:30 PM EST	Abstract	9-002 - Seizure Triggers in Persons with Epilepsy (PWE): A Cohort of 1975 Patients Fahham Asghar, MD
05:30 PM - 06:30 PM EST	Abstract	9-003 - Reduced Bone Mineral Disease in Men with Epilepsy: a Cross-Sectional Study with 178 Subjects Aline F. Dias, MD, Other
05:30 PM - 06:30 PM EST	Abstract	9-004 - The Outcome of Traumatic Intra-diploic Meningoencephalocele with Recurrent seizures - A case report and literature review of 20 cases Faisal A. Alsallom, MD
05:30 PM - 06:30 PM EST	Abstract	9-005 - A Case of Cardioneuroablation Treating Ictal Bradyarrhythmia and Expanding Seizure Therapy Options Stephen Manu, MD
05:30 PM - 06:30 PM EST	Abstract	9-006 - Encephalitis and Risk of Epilepsy Shirin Jamal Omidi, MD
05:30 PM - 06:30 PM EST	Abstract	9-007 - Associations of small vessel disease and seizures among hospitalized stroke patients Alain Z. Lekoubou Looti, MD
05:30 PM - 06:30 PM EST	Abstract	9-008 - Emergency Department Treatment of Alcohol-Related Seizures: A Retrospective Chart Review Adel Hijazi, MD
05:30 PM - 06:30 PM EST	Abstract	9-009 - NUS1 Exon 2 Deletion: A Crossover Between Epilepsy and Movement Disorders Lauren A. Terpak, MD
05:30 PM - 06:30 PM EST	Abstract	9-010 - White matter tract abnormalities are associated with executive dysfunction in temporal lobe epilepsy and hippocampal sclerosis Marina Solti, MD
05:30 PM - 06:30 PM EST	Abstract	9-011 - Improving SUDEP educational resources for Neurology health professionals and patients. Jaudat Masood, MD
05:30 PM - 06:30 PM EST	Abstract	9-012 - Sudden Unexpected Death in Epilepsy During the Cenobamate Clinical Development Program William E. Rosenfeld, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	15-001 - Implementing Extension of Community Healthcare Outcomes (ECHO) Framework to Educate Rural Populations in Complex Parkinson Disease Management Lee E. Neilson, MD
05:30 PM - 06:30 PM EST	Abstract	15-002 - An Adaptation of a Community-Based Participatory Research Framework to Promote Engagement of Native Hawaiian's in Parkinson's Disease Research Emma Krening, Other
05:30 PM - 06:30 PM EST	Abstract	15-003 - Preparing Clinicians to Provide Equitable Alzheimer’s Disease (AD) Care: What Continuing Medical Education (CME) Can Achieve Carole Drexel
05:30 PM - 06:30 PM EST	Abstract	15-004 - A Patient-centric Approach to Neuro-recovery after Acute Neurologic Injuries Poojith Nuthalapati, MD
05:30 PM - 06:30 PM EST	Abstract	15-005 - Standardized Curriculum Improves Physician and Nurse Confidence and Competence in Brain Death Zachary Hodosevich, MD
05:30 PM - 06:30 PM EST	Abstract	3-001 - Impact of the COVID-19 Pandemic on Personal Networks and Neurological Outcomes of People with Multiple Sclerosis Shruthi Venkatesh
05:30 PM - 06:30 PM EST	Abstract	3-002 - COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD during the Omicron BA.1/2 wave in Singapore Kevin Tan, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	3-003 - COVID-19 Antibody Response by Vaccine Type and Lymphocyte Count in RMS Patients on Ponesimod: Results From Phase 2 Long-term Extension Study AC-058B202 Janice Wong, MD
05:30 PM - 06:30 PM EST	Abstract	3-004 - AMA-VACC: Clinical trial assessing the immune response to SARS-CoV-2 mRNA vaccines and booster vaccination in siponimod treated patients with secondary progressive multiple sclerosis Tjalf Ziemssen, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	3-005 - Reduced humoral immune response after mRNA vaccination correlates with breakthrough SARS-CoV-2 infection in ocrelizumab-treated multiple sclerosis patients Frederik Novak, MD
05:30 PM - 06:30 PM EST	Abstract	3-006 - Recombinant antibodies binding to cytoskeletal structural proteins in post Covid-19 vaccination demyelination syndromes Amol Raisingani
05:30 PM - 06:30 PM EST	Abstract	3-007 - Anti-JC Virus Serostatus Changes Before and During the COVID-19 Pandemic in US Patients with Multiple Sclerosis (MS) Treated with Natalizumab Stephen Krieger, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	3-008 - Acute Fulminant Encephalitis in the Setting of Acute COVID-19 Infection Bassil Kherallah, MD
05:30 PM - 06:30 PM EST	Abstract	3-009 - MOG Antibody-Associated Bilateral Optic Neuritis Associated with Johnson and Johnson COVID-19 Vaccination Frighton B. Mutete, MBChB
05:30 PM - 06:30 PM EST	Abstract	3-010 - Neurological Manifestations Post-COVID-19 Vaccination: A Review of Case Studies Katherine E. Beard, MD
05:30 PM - 06:30 PM EST	Abstract	3-012 - Changing Treatment Trends for MS Patients Recently Initiated on Their First DMT Emma McFadden, PhD
05:30 PM - 06:30 PM EST	Abstract	3-013 - Cerebral Vasculitis in a patient receiving Risankizumab, an Inhibitor of Interleukin-23: First Case Report Juan P. Cabrera Pulla, MD
05:30 PM - 06:30 PM EST	Abstract	3-014 - High-dose cyclophosphamide as a rescue treatment for fulminant Marburg multiple sclerosis: A case report Alicia S. Parker, MD
05:30 PM - 06:30 PM EST	Abstract	3-015 - Multiple Sclerosis Related Trigeminal Neuralgia – Clinical Characteristics, MRI Correlates and Treatment Outcomes Sarah Germaine, DO
05:30 PM - 06:30 PM EST	Abstract	3-016 - A Familial Cohort of Adult-Onset Alexander Disease Laura Naydovich, MD
05:30 PM - 06:30 PM EST	Abstract	3-018 - Diagnosis of Coexistent Neurodegenerative Dementias in Multiple Sclerosis Diana P. Londono, MD
05:30 PM - 06:30 PM EST	Abstract	12-001 - The genetic counselor: recognizing their critical role in neurology clinics in the era of genomic medicine Jin Yun Helen Chen, MS, LCGC
05:30 PM - 06:30 PM EST	Abstract	12-002 - Clinical Management of Rett Syndrome in the Real World: A Physician Survey Damian M. May, Other
05:30 PM - 06:30 PM EST	Abstract	12-003 - Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is commonly misdiagnosed as Frontotemporal Dementia (FTD), Multiple Sclerosis (MS,) Alzheimer’s disease (AD), or other adult-onset leukodystrophies Andreas Meier, MD
05:30 PM - 06:30 PM EST	Abstract	12-004 - Substantial Burden of Illness and Mortality in Adult Men with Adrenomyeloneuropathy: A Retrospective Study of Real World Data Joshua Bonkowsky, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	12-005 - Evaluation of methodologies for indirect comparison of eplontersen and vutrisiran for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy Chafic Y. Karam, MD
05:30 PM - 06:30 PM EST	Abstract	12-006 - Regeneration and Immortality: Aging of the Jellyfish Turritopsis dohrnii Valentina Velasco
05:30 PM - 06:30 PM EST	Abstract	6-001 - Undifferentiated Inflammatory Vasculopathy: A Case Presentation Sorleen Trevino, MD
05:30 PM - 06:30 PM EST	Abstract	6-002 - Large vessel occlusion stroke presenting with coma: Not uncommon and poor prognostic sign Michael Young, MD
05:30 PM - 06:30 PM EST	Abstract	6-003 - A Case of Progressive Left Leg Weakness and Vision Changes: Focal Inflammatory Cerebral Amyloid Angiopathy Masquerading as a Glioma Cameron Mohammadi, MD
05:30 PM - 06:30 PM EST	Abstract	6-004 - Posterior Spinal Cord Infarct: To Make the Diagnosis, Think of the Unthinkable! Krystian Solis, MD
05:30 PM - 06:30 PM EST	Abstract	6-005 - A Rare Familial Case of MELAS in a 66-Year-Old Female and Her 33-Year-Old Son Radostina Iordanova, DO
05:30 PM - 06:30 PM EST	Abstract	6-006 - The Writing is on the Wall - Interesting Case of Peduncular Hallucinosis in an Adult Patient Sahil S. Suvarna, DO
05:30 PM - 06:30 PM EST	Abstract	6-007 - The Gummies Strike Again: An Emerging Stroke Mimic in New York City’s Unsuspecting Hotel Housekeepers Miryam Alkayyali, MD
05:30 PM - 06:30 PM EST	Abstract	6-008 - Mania and Hemiballismus: A rare presentation of subthalamic stroke Harinoor Mann, MBBS
05:30 PM - 06:30 PM EST	Abstract	6-010 - Acute Flaccid Paralysis as Initial Presentation of Spinal Cavernoma Khaled Gharaibeh, MD
05:30 PM - 06:30 PM EST	Abstract	6-011 - An Atypical Manifestation of Lateral Medullary Syndrome Connor Bluntson, MD
05:30 PM - 06:30 PM EST	Abstract	6-012 - Alteplase-induced facial orolingual angioedema Enrique Gomez Figueroa, MD, MSc
05:30 PM - 06:30 PM EST	Abstract	6-013 - Bronchoscopy-Associated Cerebral Arterial Air Embolism Presenting with Acute Ischemic Stroke and Status Epilepticus Harry Sutherland, MD
05:30 PM - 06:30 PM EST	Abstract	6-014 - A Case of Internal Carotid Artery Dissection Presenting With Dysgeusia Ivanna Joseph, MD
05:30 PM - 06:30 PM EST	Abstract	6-015 - Black Cohosh Induced Posterior Reversible Encephalopathy Syndrome Hanah A. Imam, MBBS
05:30 PM - 06:30 PM EST	Abstract	6-016 - Acute Paraparesis Syndrome after a Ruptured Aneurysm of the Azygos Anterior Cerebral Artery Daniel Moreno-Zambrano, MD
05:30 PM - 06:30 PM EST	Abstract	6-017 - Transient Left MCA Syndrome Triggered by a Diagnostic Lumbar Puncture in a Case of Atypical Moyamoya Syndrome Naman Bareja, MBBS
05:30 PM - 06:30 PM EST	Abstract	6-018 - A Tangled, Clotted Web: Multi-modal imaging of a thrombosed carotid web Rebecca Merrill, MD
05:30 PM - 06:30 PM EST	Abstract	6-019 - The great masquerader: recurrent ischemic strokes secondary to meningo-vascular syphilis in a 62-year-old patient with stroke risk factors Sadia Waheed, MBBS
05:30 PM - 06:30 PM EST	Abstract	6-020 - Acute and Subacute Neurovascular Impact of Cryptogenic Air Emboli Christine Gummerson, MD
05:30 PM - 06:30 PM EST	Abstract	6-021 - Reversible Neuroimaging findings associated with Kratom use. Sindhu Reddy Pisati, MD, MBBS
05:30 PM - 06:30 PM EST	Abstract	6-022 - Pulmonary Hypertension and Patent Foramen Ovale: A Rare Risk Factor for Stroke Jacob Arkin
05:30 PM - 06:30 PM EST	Abstract	6-023 - Patient with Recurrent Acute Ischemic Strokes Found to have Cryptococcal Meningitis: A Case Report Victor Wang, MD
05:30 PM - 06:30 PM EST	Abstract	6-024 - Isolated and Spontaneous Common Carotid Artery Dissection: A Case Report Ahmed Abd Elazim, MD
05:30 PM - 06:30 PM EST	Abstract	6-026 - Ischemic Cerebellar Stroke in a Young Patient with Neurofibromatosis Type 2, a Case Report Nessim Amin, MD
05:30 PM - 06:30 PM EST	Abstract	6-027 - Steal Syndrome Becomes Symptomatic While Playing Golf Deema Sawass Najjar, MD
05:30 PM - 06:30 PM EST	Abstract	6-028 - Transient Focal Neurologic Episodes in Non-Traumatic Convexity Subarachnoid Hemorrhage Avi Landman, MD
05:30 PM - 06:30 PM EST	Abstract	6-029 - Case of a Pure Arterial Malformation and Review of the Literature. Rashid A. Ahmed, MD
05:30 PM - 06:30 PM EST	Abstract	6-030 - Management of Peri-mesencephalic Hemorrhage leading to acute hydrocephalus in an infant following Mild Trauma Jacklyn Johnson, MD
05:30 PM - 06:30 PM EST	Abstract	6-031 - Acute Bilateral Hippocampal Injury Secondary to Recreational Fentanyl Use Sayyeda Zahra, MD
05:30 PM - 06:30 PM EST	Abstract	7-001 - Participant-specific interrogation of population-based data to predict cognitive decline from neuropsychiatric symptoms and neuroimaging biomarkers: A machine learning approach Jay Shah, MD
05:30 PM - 06:30 PM EST	Abstract	7-003 - Red Nucleus Volume Decrease in Healthy Aging Mikolaj Pawlak, MD PhD
05:30 PM - 06:30 PM EST	Abstract	7-004 - Within-person changes in the aging white matter: a meta-analysis and systematic review of longitudinal diffusion tensor imaging studies Andrea Mendez Colmenares, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	7-005 - Diagnostic Application of Automated Brain MRI Volumetry in Comparing Alzheimer Disease, Behavioral Variant Frontotemporal Dementia and Traumatic Brain Injury Somayeh Meysami, MD
05:30 PM - 06:30 PM EST	Abstract	7-006 - Nucleus Basalis of Meynert degeneration predicts cognitive decline in Corticobasal Syndrome Daniele Urso, MD
05:30 PM - 06:30 PM EST	Abstract	7-008 - White Matter and Gray Matter Changes Related to Cognition in Community populations Wenxin Li
05:30 PM - 06:30 PM EST	Abstract	7-009 - Visuospatial Dysfunction in Alzheimer's Disease Maps to a Brain Network Sheena Baratono, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	1-001 - A Case of Surfer’s Myelopathy– Insights Into Early Management Leading to Radiographic and Neurologic Improvement Sarah E. Bellatti
05:30 PM - 06:30 PM EST	Abstract	1-002 - Serum immunoglobulin G level reduction as a predictor of short-term improvement in patients with myasthenia gravis undergoing plasmapheresis Shingo Konno, MD
05:30 PM - 06:30 PM EST	Abstract	1-003 - A Case of Botulism After Intramuscular Injection of Botulinum Toxin Marc Daou, MD
05:30 PM - 06:30 PM EST	Abstract	1-004 - A Therapeutic Dilemma of Venous Thromboembolism in the Setting of Odontogenic Brain and Intramedullary Spinal Cord Abscesses: Case Report and Review of Literature Courtney Venegas, MD
05:30 PM - 06:30 PM EST	Abstract	1-005 - Spinal cord infarction after transcatheter aortic valve replacement: a case report Talita D'Aguiar Rosa, MD
05:30 PM - 06:30 PM EST	Abstract	1-006 - Guillain-Barré Syndrome Mimicking Brainstem Death Following Traumatic Intracerebral Hemorrhage Eoin Finegan, MBBS
05:30 PM - 06:30 PM EST	Abstract	10-001 - Botulinum Toxin-A Treatment of Post-Stroke Spasticity Is Associated with Changes in Interhemispheric Parietal Cortex Connectivity Petr Hlustik, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	10-002 - Prediction of Post-stroke Motor Recovery Benefits from Measures of Sub-acute Widespread Network Damages Cyprien Rivier, MD
05:30 PM - 06:30 PM EST	Abstract	10-003 - A Gamified Electromyographic Computer Interface to Study the Emergence of Motor Control Abnormalities after Stroke Adarsh Mavathaveedu
05:30 PM - 06:30 PM EST	Abstract	10-004 - MS Rehabilitation Research During the COVID Pandemic: Participant and Therapist Satisfaction with Remote Delivery Michelle Cameron, MD
05:30 PM - 06:30 PM EST	Abstract	10-005 - The Efficacy of Vestibular Rehabilitation Therapy for Mild Traumatic Brain Injury: A Systematic Review and Meta-analysis Ammar Aljabri, Jr.
05:30 PM - 06:30 PM EST	Abstract	10-006 - Survival in Amyotrophic Lateral Sclerosis Patients Treated with Edaravone – a Pooled Analysis of 2845 Patients
05:30 PM - 06:30 PM EST	Abstract	10-007 - A Novel Tele-rehabilitation Program Aimed at Fall Prevention in Parkinson’s Disease Andrea Hernandez
05:30 PM - 06:30 PM EST	Abstract	10-008 - Facial Emotion Processing Changes in Functional Seizures after Neurobehavioral Therapy Jerzy P. Szaflarski, MD, PhD, FAAN
05:30 PM - 06:30 PM EST	Abstract	10-009 - Moderate-to-high Intensity Group Exercise Improves Function of Stroke Survivors Se Hee Jung, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	10-010 - Leg Activity Measure (LegA) sensitivity to change following treatment of lower limb spasticity with a single cycle of abobotulinumtoxinA in an ambulant population Christian Hannes
05:30 PM - 06:30 PM EST	Abstract	10-011 - Abnormal Thalamic Functional Connectivity Correlates With Cardiorespiratory Fitness and Physical Activity in Progressive Multiple Sclerosis Tetsu Morozumi, PT
05:30 PM - 06:30 PM EST	Abstract	10-012 - Treating Upper Limb Spasticity With OnabotulinumtoxinA: Subgroup Analysis of US Practice Patterns From the ASPIRE Study Marjan Sadeghi, PharmD
05:30 PM - 06:30 PM EST	Abstract	10-013 - Real-World Clinical Utilization Differences of onabotulinumtoxinA and abobotulinumtoxinA in Upper Limb Spasticity Rita Singh, PharmD
05:30 PM - 06:30 PM EST	Abstract	10-014 - The Canadian Registry for Amyloidosis Research: A national multi-disciplinary registry for real-world evidence Dina Namiranian, MD
05:30 PM - 06:30 PM EST	Abstract	10-015 - Predictors of Mechanical Ventilation Among 1960 Obese Patients Admitted With Guillain-Barré syndrome in the United States Sailaja Sanikommu, MBBS
05:30 PM - 06:30 PM EST	Abstract	4-001 - Identification of Neuropsychological Phenotypes in Pediatric Multiple Sclerosis Using Unsupervised Machine Learning Paolo Preziosa
05:30 PM - 06:30 PM EST	Abstract	4-002 - Analysis Of Differentially Expressed Genes By RNA-Sequencing In 38 Cases of Rasmussen Encephalitis: New Insights on Non-Inflammatory Pathways Luca Bartolini, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	4-003 - Rates of Depression and Suicidality in Pediatric-Onset Multiple Sclerosis: A Pilot Study
05:30 PM - 06:30 PM EST	Abstract	4-004 - The Spatiotemporal Progression of Myelination Drives Pathology in Canavan Disease Amanda M. Nagy, MD
05:30 PM - 06:30 PM EST	Abstract	4-005 - Complications, Sequelae and Case Fatality Rate in Pediatric Patients with Meningitis in Dominican Republic. Danilo A. Peralta
05:30 PM - 06:30 PM EST	Abstract	4-007 - Effects of Remote Learning during the COVID-19 Lockdown on Children’s Visual Health: A Systematic Review Sofia Ramirez Guerrero, MD
05:30 PM - 06:30 PM EST	Abstract	4-008 - Energy Expenditure Index Correlates with Motor and Sensory Impairments and Disease Severity in Adrenomyeloneuropathy Manouchehr Amanat Yazdi, MD
05:30 PM - 06:30 PM EST	Abstract	4-009 - Decreased RNA polymerase III Expression Leads to Several Defects in Oligodendrocyte-Lineage Development Julia Macintosh, Other
05:30 PM - 06:30 PM EST	Abstract	4-010 - The ABCDs of CMV Manasa Sudheendra, MBBS
05:30 PM - 06:30 PM EST	Abstract	4-011 - Characterization of Childhood Neurodegeneration and Associated Ataxia in UBTF-Related Disorder Amanda M. Nagy, MD
05:30 PM - 06:30 PM EST	Abstract	4-012 - Pediatric FLAMES and Status Epilepticus: A Heated Combination Alexander Ankar, MD
05:30 PM - 06:30 PM EST	Abstract	13-001 - Chronic Herpes Simplex Virus Encephalitis: Two Surgical Cases with Novel Neuropathologic Findings Kirsten Sjonnesen, MD
05:30 PM - 06:30 PM EST	Abstract	13-002 - HSV-2 Retinitis and Encephalitis Masquerading as Giant Cell Arteritis and Acute Ischemic Stroke of the Midbrain Harry Sutherland, MD
05:30 PM - 06:30 PM EST	Abstract	13-003 - Postherpetic pruritus successfully treated with Onabotulinum toxin: A case report Juliana Stoilova, MD
05:30 PM - 06:30 PM EST	Abstract	13-004 - A Case of HSV-2 Meningitis Retention Syndrome Raissa Aoun, MD
05:30 PM - 06:30 PM EST	Abstract	13-005 - Herpes Simplex Virus (HSV), Varicella-Zoster Virus (VZV), and Cryptococcal Infections Associated With Sphingosine-1-Phosphate Receptor (S1PR) Modulators: A Review Kanika Sharma
05:30 PM - 06:30 PM EST	Abstract	13-006 - Reactivation of Varicella-Zoster Virus: Consequence of COVID-19? Shaweta Khosa
05:30 PM - 06:30 PM EST	Abstract	5-001 - Hypermanganesemia with Dystonia Type 2: A Rare Entity. Bhaswar Bhattacharya, Jr.
05:30 PM - 06:30 PM EST	Abstract	5-005 - Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Anterocollis and Retrocollis Marjan Sadeghi, PharmD
05:30 PM - 06:30 PM EST	Abstract	5-006 - SYNCHRONIZE: Real-World Retrospective Review of Safety in Patients Treated With OnabotulinumtoxinA for More Than 1 Therapeutic Indication: An Epidemiologic Perspective Grace I. Forde, MD
05:30 PM - 06:30 PM EST	Abstract	5-007 - Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults Cynthia L. Comella, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	5-008 - Adherence to Botulinumtoxin Treatment: A 2-year Retrospective Claims Database Analysis
05:30 PM - 06:30 PM EST	Abstract	5-009 - Benefit of Multiple IncobotulinumtoxinA Injections for Pain Reduction in Adult Patients with Limb Spasticity: an Analysis of Pooled Data from Phase 2 and 3 Studies Jorg Wissel
05:30 PM - 06:30 PM EST	Abstract	5-010 - Effects of Videogaming on Attention and Conduct in Adolescents with Tourette's Syndrome Brendan Colgan, MD
05:30 PM - 06:30 PM EST	Abstract	5-011 - Design of a Phase 3 Maintenance-of-Effect Trial of Ecopipam in Tourette Syndrome Timothy Cunniff, PharmD
05:30 PM - 06:30 PM EST	Abstract	5-012 - Substance misuse in adults with primary tic disorders Christelle Nilles, MD
05:30 PM - 06:30 PM EST	Abstract	5-013 - Gender Identity and Treatment Response in Patients with Functional Tic-Like Behavior Sushma Kola, MD
05:30 PM - 06:30 PM EST	Abstract	5-014 - Dystonia as a Manifestation of Methadone Withdrawal Pukhraj Nijhar
05:30 PM - 06:30 PM EST	Abstract	5-015 - Case Report: Acquired Transient Generalized Dyskinesia Secondary to Fentanyl in a Patient with Parkinson’s Disease Ann N. Ly, MD
05:30 PM - 06:30 PM EST	Abstract	5-016 - Imperfect Pitch: a Cellist’s Struggle with Tics, PRRT2, and Carbamazepine Matthew Feldman, MD
05:30 PM - 06:30 PM EST	Abstract	2-001 - Benefit-Risk Assessment of Atogepant: A Post Hoc Analysis of the ADVANCE Trial Stephanie J. Nahas, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	2-002 - Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: Second Interim Analysis of the Observational PEARL Study Verena Ramirez Campos, MD
05:30 PM - 06:30 PM EST	Abstract	2-003 - Long-Term Preventive and Acute Treatment of Migraine With Rimegepant Improves Health Related Quality of Life Jelena M. Pavlovic, MD, PhD
05:30 PM - 06:30 PM EST	Abstract	2-004 - Real-Life Experience with Erenumab Therapy in the Episodic and Chronic Migraine. Fatemah Alshawaf, MD
05:30 PM - 06:30 PM EST	Abstract	2-005 - No ‘Wearing-Off Effect’ Seen with Fremanezumab in the Real-World: Retrospective, Claims-Based Analysis of Migraine-Related Healthcare Resource and Acute Medication Use Mario Ortega, PhD
05:30 PM - 06:30 PM EST	Abstract	2-006 - Safety and Tolerability of Rimegepant Every Other Day for Preventive Treatment of Migraine Plus As-Needed for Acute Treatment of Migraine: Results from A 52-Week, Open-Label Extension Phase Richard B. Lipton, MD, FAAN
05:30 PM - 06:30 PM EST	Abstract	2-007 - Adherence and Persistence of Calcitonin Gene-Related Peptide Monoclonal Antibodies in Patients with Migraine: A Real-World Study Oralee J. Varnado, PhD
05:30 PM - 06:30 PM EST	Abstract	2-008 - Assessment of the Potential for Drug–Drug Interactions Between INP104 and Gepants for Migraine Management Using a Model-based Approach Shivang Joshi, MD
05:30 PM - 06:30 PM EST	Abstract	2-009 - Real-World Effectiveness of Eptinezumab after Treatment with Subcutaneous CGRP Monoclonal Antibodies in Patients with Migraine Emily Casaletto
05:30 PM - 06:30 PM EST	Abstract	2-010 - Headwork as innovative tool for monitoring MABs efficacy in migraine and their influence on work activity Cristina Tassorelli
05:30 PM - 06:30 PM EST	Abstract	2-011 - Final results of the SPECTRE study: real-world data giving an insight into the treatment of migraine patients with erenumab in Germany Cordula Weiss, PhD
05:30 PM - 06:30 PM EST	Abstract	2-012 - Galcanezumab effects on incidence of headache after occurrence of triggers, prodromes, and aura in responders, non-responders, super-responders and super non-responders Sait Ashina, MD
05:30 PM - 06:30 PM EST	Abstract	11-001 - Can Endoplasmic Reticulum Stress Responses Predict the Development of CIPN in Patients Receiving Paclitaxel-based Therapy? Michael E. Limia, MD
05:30 PM - 06:30 PM EST	Abstract	11-002 - Diagnostic Factors associated with Meningeal Dissemination of Lymphoid Neoplasms Gabriel D. Pinilla Monsalve, MD, MSc
05:30 PM - 06:30 PM EST	Abstract	11-003 - Nivolumab-induced Central Nervous System (CNS) Vasculitis Brought on by a Steroid Taper Nishika Karbhari, MD
05:30 PM - 06:30 PM EST	Abstract	11-004 - Neurological Complications of Immune Checkpoint Inhibitors Abida P. Babu, MD, MBBS
05:30 PM - 06:30 PM EST	Abstract	11-005 - Delayed Onset ICANS Leading to Bilateral Cranial Neuropathies: Two Case Reports Kelsey Beck, MD
05:30 PM - 06:30 PM EST	Abstract	11-006 - Delayed malignant cerebellar posterior reversible encephalopathy syndrome secondary to (CLAG-M) and venetoclax regimen. Isha Snehal, MBBS

Faculty Disclosures
Paul Winner, DO, FAAN	Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for lilly. The institution of Dr. Winner has received research support from Amgen. The institution of Dr. Winner has received research support from Allergan. The institution of Dr. Winner has received research support from Lundbeck . The institution of Dr. Winner has received research support from Novartis. The institution of Dr. Winner has received research support from Lilly. The institution of Dr. Winner has received research support from Teva. The institution of Dr. Winner has received research support from Supernus. The institution of Dr. Winner has received research support from Biogen. The institution of Dr. Winner has received research support from Avinar. The institution of Dr. Winner has received research support from SAMUS.
Jeremy D. Schmahmann, MD, FAAN	Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Christopher Goetz, MD, FAAN	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Cynthia L. Comella, MD, FAAN	Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Michael R. Sperling, MD, FAAN	Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Joseph Jankovic, MD, FAAN	Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
David M. Simpson, MD, FAAN	Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Simpson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz.
Stewart A. Factor, DO, FAAN	Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Peter Goadsby, MD, PhD, FRS	Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kallyope. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seaport Therapeutics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddy's. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities.
Grace I. Forde, MD	Dr. Forde has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Sheena K. Aurora, MD	Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Scott S. Zamvil, MD, PhD, FAAN	Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
Aikaterini Kompoliti, MD, FAAN	Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kompoliti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scion. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Kompoliti has received research support from Emalex. Dr. Kompoliti has received research support from TEVA. Dr. Kompoliti has received research support from Theravance. Dr. Kompoliti has received research support from Ipsen. Dr. Kompoliti has received research support from Theravance.
Alan R. Hirsch, MD, FACP	Dr. Hirsch has nothing to disclose.
Rami Burstein, PhD	Dr. Burstein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan. Dr. Burstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Burstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Burstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Burstein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Burstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dr. Reddy. Dr. Burstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Burstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Burstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Percept. Dr. Burstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Burstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Theranica. The institution of Dr. Burstein has received research support from Allergan. The institution of Dr. Burstein has received research support from Teva. The institution of Dr. Burstein has received research support from Eli Lilly. The institution of Dr. Burstein has received research support from Dr. Reddy.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
William D. Gaillard, MD	The institution of Dr. Gaillard has received research support from all federal or foundation grants, NINDS, NIDCD, NICHD, NSF ,PERF.
Giancarlo Logroscino, MD, PhD, FAAN	Dr. Logroscino has nothing to disclose.
Jeff Kraakevik, MD, FAAN	Dr. Kraakevik has stock in Multiple companies. The institution of Dr. Kraakevik has received research support from Parkinson Foundation. The institution of Dr. Kraakevik has received research support from Syngeric.
Natalia S. Rost, MD, MPH, FAAN, FAHA	Dr. Rost has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for American Academy of Neurology. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
Aneesh B. Singhal, MD, FAAN	An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (Education) with Biogen.
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
David D. Song, MD, PhD	Dr. Song has nothing to disclose.
Donald Gilbert, MD, FAAN	Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex Biosciences. The institution of Dr. Gilbert has received research support from PTC Therapeutics. The institution of Dr. Gilbert has received research support from Department of Defense. The institution of Dr. Gilbert has received research support from Quince Therapeutics. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $10,000-$49,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
William E. Rosenfeld, MD, FAAN	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science.
Jerzy P. Szaflarski, MD, PhD, FAAN	Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Imran I. Ali, MD, FAAN	Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Spyridon Papapetropoulos, MD, PhD	Dr. Papapetropoulos has received personal compensation for serving as an employee of Vigil Neuroscience . Dr. Papapetropoulos has received personal compensation for serving as an employee of Bionomics Ltd. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Lipocine Inc. Dr. Papapetropoulos has stock in Vigil Neuroscience. Dr. Papapetropoulos has stock in Lipocine. Dr. Papapetropoulos has stock in Bionomics Ltd.
Emmanuel Roze, MD, PhD	Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merz. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving as a Consultant for orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Roze has received research support from merz. The institution of Dr. Roze has received research support from Orkyn. Dr. Roze has received research support from elivie. The institution of Dr. Roze has received research support from allergan. The institution of Dr. Roze has received research support from fondation desmarest. The institution of Dr. Roze has received research support from everpharma. Dr. Roze has received research support from AMADYS. The institution of Dr. Roze has received research support from ADCY5.org. The institution of Dr. Roze has received research support from agence nationale de la recherche. The institution of Dr. Roze has received research support from société française de médecine esthétique. The institution of Dr. Roze has received research support from dystonia medical research foundation.
Kevin Tan, MD, FAAN	Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck.
Helio Afonso G. Teive, MD, PhD, FAAN	Dr. Teive has nothing to disclose.
Lara Jehi, MD	Dr. Jehi has nothing to disclose.
Maria P. Amato, PhD	Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Paola Valsasina	Paola Valsasina has nothing to disclose.
Petr Kanovsky, PhD	Dr. Kanovsky has nothing to disclose.
Petr Hlustik, MD, PhD	The institution of Prof. Hlustik has received research support from Czech Health Research Council (AZV CR).
	No disclosure on file
Massimiliano Mirabella, MD	Dr. Mirabella has nothing to disclose.
Web Ross, MD	The institution of Dr. Ross has received research support from Michael J Fox Foundation. The institution of Dr. Ross has received research support from NIH.
Stephen B. Shrewsbury, MD	Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Mario F. Mendez, MD, PhD, FAAN	Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Education Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Rana K. Zabad, MD, FAAN	Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene/BMS. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Neurosciences. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Zabad has received research support from Adamas. The institution of Dr. Zabad has received research support from Biogen. The institution of Dr. Zabad has received research support from Novartis. The institution of Dr. Zabad has received research support from Sun Pharma. The institution of Dr. Zabad has received research support from Parexel & MedDay Pharmaceuticals.
Jeremy S. Chataway, MD	Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NerveGen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Yonas E. Geda, MD	The institution of Dr. Geda has received research support from NIH. Dr. Geda has received intellectual property interests from a discovery or technology relating to health care.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Timothy R. Smith, MD	The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vorso/Nesos. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder/Lundbeck. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurolief. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Smith has stock in United Health Group. The institution of Dr. Smith has received research support from Aeon. The institution of Dr. Smith has received research support from Alder/Lundbeck. The institution of Dr. Smith has received research support from Alnylam. The institution of Dr. Smith has received research support from Amgen. The institution of Dr. Smith has received research support from Abbvie/Allergan. The institution of Dr. Smith has received research support from Biohaven. The institution of an immediate family member of Dr. Smith has received research support from Eliem Pharmaceuticals. The institution of Dr. Smith has received research support from Lilly. The institution of Dr. Smith has received research support from Pfizer. The institution of Dr. Smith has received research support from Nocira. The institution of Dr. Smith has received research support from Novo Nordisk. The institution of Dr. Smith has received research support from Teva. The institution of Dr. Smith has received research support from Theranica. The institution of Dr. Smith has received research support from Vorso/Nesos. Dr. Smith has a non-compensated relationship as a Board Member with National Headache Foundation that is relevant to AAN interests or activities.
Francisco M. Branco Germiniani, MD	Dr. Branco Germiniani has nothing to disclose.
Deanna Saylor, MD, MHS, FAAN	Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from American Academy of Neurology. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Educational Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Xue Ming, MD	Dr. Ming has nothing to disclose.
Jerry Lin, BS	Mr. Lin has nothing to disclose.
Mark Keegan, MD, FAAN	Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Philip De Jager, MD, PhD	Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from puretech.
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Stephanie J. Nahas, MD, FAAN	Dr. Nahas has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AbbVie. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a expert for CME activities with Medscape/WebMD. Dr. Nahas has a non-compensated relationship as a Board Member-at-Large with American Headache Society that is relevant to AAN interests or activities. Dr. Nahas has a non-compensated relationship as a Executive Board Member with The Headache Alliance that is relevant to AAN interests or activities.
Peter J. McAllister, MD, FAAN	Dr. McAllister has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for pfizer. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck.
Tjalf Ziemssen, MD, FAAN	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Jose L. Ruiz-Sandoval, MD	Dr. Ruiz-Sandoval has nothing to disclose.
Khashayar Dashtipour, MD, PhD	Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acadia. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for kyowa kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal . Dr. Dashtipour has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for kyowa Kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for amneal . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Dashtipour has received research support from Abbvie. The institution of Dr. Dashtipour has received research support from ipsen. The institution of Dr. Dashtipour has received research support from amneal.
Patrick S. Reynolds, MD, FAAN	Dr. Reynolds has nothing to disclose.
Sookyong Koh, MD, PhD	No disclosure on file
Michelle Cameron, MD	Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Jaime Imitola, MD, FAAN	The institution of Dr. Imitola has received research support from Genentech. Dr. Imitola has a non-compensated relationship as a Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Imitola has a non-compensated relationship as a Committee Member with International Society for Stem Cell Research that is relevant to AAN interests or activities.
P. D. Charles, MD, FAAN	Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceraxis. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax. The institution of Dr. Charles has received research support from AskBio. The institution of Dr. Charles has received research support from BlueRock. The institution of Dr. Charles has received research support from AbbVie. The institution of Dr. Charles has received research support from Ipsen.
Maria Trojano	Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Amber Salter, PhD	Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Ihtsham Haq, MD, FAAN	The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Gerald Raymond, MD	Dr. Raymond has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Bluebird bio. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Travere. Dr. Raymond has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Dept of HHS.
H. A. Jinnah, MD, PhD, FAAN	Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
David B. Kudrow, MD	Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Toshiki Fujioka, MD	Dr. Fujioka has nothing to disclose.
Dimos Dimitrios D. Mitsikostas, MD, PhD	The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Leli Lilly. The institution of Dr. Mitsikostas has received research support from Eli Lilly. Dr. Mitsikostas has a non-compensated relationship as a Co-Chair of Headache Panel with EAN that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a President with Hellenic Headache Society that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with J Headache Pain that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with Frontier Neurology that is relevant to AAN interests or activities.
Tamara M. Pringsheim, MD, FAAN	The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Francesco Patti, MD	Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Almirall. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla. Dr. Patti has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Franco Granella	Franco Granella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Franco Granella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Franco Granella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono.
Florian Eichler, MD	An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atlas Venture. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leal Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Tx. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Therapeutics. The institution of Dr. Eichler has received research support from ASPA Therapeutics. The institution of Dr. Eichler has received research support from Abbvie. The institution of Dr. Eichler has received research support from Ionis Pharmaceuticals.
Rachel A. Farrell, MD	The institution of Dr. Farrell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharma / Jazz. The institution of Dr. Farrell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz.
Rami Massie, MD	Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gowlingwlg. Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with Pfizer. Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Argenx.
Suparna R. Krishnaiengar, MD	Dr. Krishnaiengar has nothing to disclose.
Rashmi B. Halker Singh, MD, FAAN	Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Halker Singh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology & Neuroscience Reports. Dr. Halker Singh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache Journal. Dr. Halker Singh has received publishing royalties from a publication relating to health care. Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Pri-med. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Medscape.
Sait Ashina, MD	Dr. Ashina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ashina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer.
Patrick Lefebvre	No disclosure on file
Sona Narula, MD	Dr. Narula has received personal compensation in the range of $0-$499 for serving as a Consultant for Medscape .
Mikolaj Pawlak, MD PhD	Dr. Pawlak has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Surgalign . Dr. Pawlak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Pawlak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Inteneural Networks Inc. Dr. Pawlak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RSQ. Dr. Pawlak has received publishing royalties from a publication relating to health care.
Prashanthi Vemuri, PhD	The institution of Dr. Vemuri has received research support from NIH.
W. C. LaFrance, Jr., MD, MPH, FAAN	Dr. LaFrance has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medico-legal work.. The institution of Dr. LaFrance has received research support from Department of Defense. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has a non-compensated relationship as a Steering Committee Member with Xenon that is relevant to AAN interests or activities.
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Leonardo F. Bonilha, MD	Dr. Bonilha has nothing to disclose.
Angeli Mayadev, MD	Dr. Mayadev has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Mayadev has received research support from Ipsen.
Giacomo Lus	Giacomo Lus has nothing to disclose.
Richard Zorowitz	Richard Zorowitz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SPR Therapeutics. The institution of Richard Zorowitz has received research support from Ipsen Pharmaceuticals. Richard Zorowitz has received publishing royalties from a publication relating to health care.
Andrew H. Ahn, MD, PhD	Dr. Ahn has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Liying Cui, PhD	No disclosure on file
Wayne W. Feng, MD, FAAN	Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Namsa. The institution of Dr. Feng has received research support from NIH. The institution of Dr. Feng has received research support from American heart association . The institution of Dr. Feng has received research support from Ipsen.
Chafic Y. Karam, MD	Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied therapeutics. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intellia. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex.
Kevin M. Kelly, MD, PhD	Dr. Kelly has nothing to disclose.
Shingo Konno, MD	Dr. Konno has nothing to disclose.
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Mark M. Lin, MD, PhD, FAAN	Dr. Lin has nothing to disclose.
Jesus E. Pina-Garza, MD	Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk. Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Pina-Garza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group/Acadia. Dr. Pina-Garza has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Same as consultant disclosure. Dr. Pina-Garza has received publishing royalties from a publication relating to health care.
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Roy E. Strowd III, MD, FAAN	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Qi Xu, MD	Dr. Xu has nothing to disclose.
Zongqi Xia, MD, PhD	The institution of Dr. Xia has received research support from National Institute of Health. The institution of Dr. Xia has received research support from Genentech/Roche.
Jane B. Allendorfer, PhD	The institution of Dr. Allendorfer has received research support from National Institutes of Health. The institution of Dr. Allendorfer has received research support from Evelyn F. McKnight Brain Institute. The institution of Dr. Allendorfer has received research support from LivaNova, Inc. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic. Dr. Allendorfer has received personal compensation in the range of $0-$499 for serving as a Examiner with University of Auckland. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International League Against Epilepsy. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Allendorfer has a non-compensated relationship as a Scientific Program Committee Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Allendorfer has a non-compensated relationship as a Editorial Board Member with Epilepsy and Behavior Reports that is relevant to AAN interests or activities.
Steven K. Baker, MD	Dr. Baker has nothing to disclose.
Riley Bove, MD, FAAN	Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.
Nancy Chiaravalloti	The institution of Nancy Chiaravalloti has received research support from NIH. The institution of Nancy Chiaravalloti has received research support from NIDILRR.
John DeLuca, PhD, ABPP	Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. DeLuca has received research support from Biogen.
Marwa Elamin, MD, PhD	Dr. Elamin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche .
Walter J. Hader, MD	No disclosure on file
Andreas Hartmann, MD	No disclosure on file
Jelena M. Pavlovic, MD, PhD	Dr. Pavlovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Pavlovic has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Vicki A. Ramsey-Williams, MD, PhD	Dr. Ramsey-Williams has nothing to disclose.
Christoph J. Schankin, MD	The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grünenthal. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Schankin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Schankin has stock in Zynnon.
Siddharth Sehgal, MD	Dr. Sehgal has nothing to disclose.
Qingliang Wang, MD PhD	The institution of Dr. Wang has received research support from Maimonides Research & Development Foundation.
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Michiko K. Bruno, MD, FAAN	The institution of Dr. Bruno has received research support from Michael J. Fox Foundation . The institution of Dr. Bruno has received research support from PIKO. The institution of Dr. Bruno has received research support from CurePSP. The institution of Dr. Bruno has received research support from Parkinson's Foundation .
Janice Wong, MD	Dr. Wong has received personal compensation for serving as an employee of Janssen Research & Development. Dr. Wong has received personal compensation for serving as an employee of Biogen. Dr. Wong has stock in Biogen. Dr. Wong has stock in Janssen Research & Development.
Ira M. Turner, MD	Dr. Turner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan, Amgen, Novartis, Teva, Lilly, Lundbeck, Biohaven,Impel. Dr. Turner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen, Teva, Allergan, Biohaven, Lilly, Lundbeck, Theranica, Revance. Dr. Turner has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan, Amgen, Biohaven, Teva, Novartis, Lundbeck, Lilly. The institution of Dr. Turner has received research support from Allergan, Amgen, Biohaven, Lilly, Lundbeck, Theranica.
Natalya Shneyder, MD	Dr. Shneyder has nothing to disclose.
Anthony Feinstein, MD	Anthony Feinstein, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis, Biogen, Roche and Sanofi-Genzyme. The institution of Anthony Feinstein, MD has received research support from Multiple Sclerosis Society of Canada. Anthony Feinstein, MD has received publishing royalties from a publication relating to health care.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Naeem Mahfooz, MD	Dr. Mahfooz has nothing to disclose.
Massimiliano Copetti	No disclosure on file
Pavel Hok, MD	Dr. Hok has nothing to disclose.
Pascal Maisonobe	Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma. Pascal Maisonobe has received personal compensation for serving as an employee of Ipsen.
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
James Rabinov	James Rabinov has nothing to disclose.
Cristina Valencia Sanchez, MD	Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Valencia Sanchez has a non-compensated relationship as a member of the medical advisory board with The MOG Project that is relevant to AAN interests or activities.
Adam De Havenon, MD, FAAN	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Jonathan H. Smith, MD	Dr. Smith has received personal compensation for serving as an employee of AbbVie. Dr. Smith has stock in AbbVie.
Amar Dhand, MD, DPhil	Dr. Dhand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ECHAS, LLC. Dr. Dhand has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ultress Quinn. The institution of Dr. Dhand has received research support from NIH. Dr. Dhand has received intellectual property interests from a discovery or technology relating to health care.
Michael D. Fox, MD, PhD	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Deepti Zutshi, MD, FAAN	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Kogul Arumaithurai, MD	Dr. Arumaithurai has nothing to disclose.
Tania Reyna, MD, FAAN	Dr. Reyna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Dr. Reyna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics .
Jimmy Holder, MD	Dr. Holder has received personal compensation in the range of $0-$499 for serving as a Consultant with Stoke Pharmaceutical.
Ryna Then, MD, FAAN	Dr. Then has nothing to disclose.
Divyajot Sandhu, MD, MBBS	Dr. Sandhu has nothing to disclose.
Sahar Zafar, MD	Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Zafar has received research support from NIH. Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker for a lecture with Marinus.
Shivang Joshi, MD	Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Joshi has received personal compensation in the range of $0-$499 for serving as a Consultant for Nerivio. Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lundbeck. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for scilex. The institution of Dr. Joshi has received research support from Biohaven.
Maysaa M. Basha, MD, FAAN	Dr. Basha has nothing to disclose.
Ania Busza, MD, PhD	Dr. Busza has received research support from NIH/NINDS. Dr. Busza has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Paolo Federico, MD, PhD	Dr. Federico has nothing to disclose.
Preet M. Varade, MD	Dr. Varade has nothing to disclose.
Amy T. Waldman, MD	Dr. Waldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has or had stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Roche/Genentech. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Calico. Dr. Waldman has received publishing royalties from a publication relating to health care. Dr. Waldman has received publishing royalties from a publication relating to health care.
Faisal A. Alsallom, MD	Dr. Alsallom has nothing to disclose.
Muhammad H. Jaffer, MD	Dr. Jaffer has nothing to disclose.
Nathaniel M. Robbins, MD	Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Red Nucleus. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for TDG Health. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Life Science Consulting. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Robbins has received research support from Diamond Endowment Fund. The institution of Dr. Robbins has received research support from Reeves Endowment Fund. The institution of Dr. Robbins has received research support from Institute for Ethnomedicine. The institution of Dr. Robbins has received research support from Theravance. The institution of Dr. Robbins has received research support from Dysautonomia International. The institution of Dr. Robbins has received research support from National Institute of Health. The institution of Dr. Robbins has received research support from Vertex pharmaceutical. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as a Locums neurohospitalist with Hayes Locums. Dr. Robbins has received personal compensation in the range of $500-$4,999 for serving as a Speaker with The Dysautonomia Project.
Tatiana Sidorenko, MD, PhD	Dr. Sidorenko has received personal compensation for serving as an employee of Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical company of Johnson&Johnson. Dr. Sidorenko has stock in Johnson&Johnson.
Jasem Y. Al-Hashel, MD	Dr. Al-Hashel has nothing to disclose.
Hesham A. Allam, MD	Dr. Allam has nothing to disclose.
Sepideh Mokhtari, MD	Dr. Mokhtari has nothing to disclose.
Luiz H. Castro, MD	Dr. Castro has nothing to disclose.
Ajaz Sheikh, MD	Dr. Sheikh has nothing to disclose.
Ulrik Dalgas	Ulrik Dalgas has received personal compensation for serving as an employee of Roche. Ulrik Dalgas has received personal compensation for serving as an employee of Bristol Meyers Squibb.
Bichun Ouyang	Bichum Ouyang has nothing to disclose.
Verena Ramirez Campos, MD	Dr. Ramirez Campos has received personal compensation for serving as an employee of teva.
Priyanka Sabharwal, MD, MBBS, FAAN	Dr. Sabharwal has nothing to disclose.
Jordan S. Dubow, MD	Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revalesio .
Licia Grazzi, MD	Dr. Grazzi has received personal compensation in the range of $0-$499 for serving as a Consultant for EliLilly. Dr. Grazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan-abbvie.
Joshua Bonkowsky, MD, PhD	Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Passage Bio. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bonkowsky has stock in Orchard. The institution of Dr. Bonkowsky has received research support from NIH. The institution of Dr. Bonkowsky has received research support from ELA. An immediate family member of Dr. Bonkowsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care.
Messoud Ashina, MD, PhD	Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GlaxoSmithKline. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Incyte. The institution of Dr. Ashina has received research support from The Lundbeck Foundation. The institution of Dr. Ashina has received research support from Novo Nordisk Foundation . The institution of Dr. Ashina has received research support from Danish National Research Foundation . Dr. Ashina has received publishing royalties from a publication relating to health care.
Alberto Esquenazi, MD	Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen and Allergan. Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen and Allergan. The institution of Dr. Esquenazi has received research support from Ipsen, Allergan and Merz.
Sarah R. Risen, MD	Dr. Risen has nothing to disclose.
Alicia S. Parker, MD	An immediate family member of Dr. Parker has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sanara Med Tech. An immediate family member of Dr. Parker has stock in Sanara Med Tech. An immediate family member of Dr. Parker has stock in Rochal Industries. An immediate family member of Dr. Parker has stock in Rochal Parnters. The institution of Dr. Parker has received research support from Texas Alzheimer's Research and Care Consortium. The institution of an immediate family member of Dr. Parker has received research support from Rochal Industries. An immediate family member of Dr. Parker has received intellectual property interests from a discovery or technology relating to health care.
Erin Longbrake, MD, PhD, FAAN	Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Longbrake has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Longbrake has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Longbrake has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ACTRIMS. Dr. Longbrake has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Longbrake has received research support from Genentech. The institution of Dr. Longbrake has received research support from NINDS K23. The institution of Dr. Longbrake has received research support from Robert Patterson Leet Trust. The institution of Dr. Longbrake has received research support from Biogen. The institution of Dr. Longbrake has received research support from National MS Society. The institution of Dr. Longbrake has received research support from Department of Defense. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with Department of Defense (CDMRP). Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Programmatic Review with Department of Defense (CDMRP). Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with National Institute of Health .
Gracia C. Mui, MD	Dr. Mui has nothing to disclose.
Edward J. Gettings, DO	Dr. Gettings has nothing to disclose.
Geetanjali S. Rathore, MD, FAAN	Dr. Rathore has nothing to disclose.
Christopher Perrone, MD	The institution of Dr. Perrone has received research support from Genentech / Hoffman-La Roche.
Anum H. Riaz, MD	Dr. Riaz has nothing to disclose.
Fay Gao, MD	Dr. Gao has nothing to disclose.
Shitiz K. Sriwastava, MBBS	Dr. Sriwastava has nothing to disclose.
Alessandro Meani	Alessandro Meani has nothing to disclose.
Alvino Bisecco	Alvino Bisecco has nothing to disclose.
Cyrus A. Raji, MD, PhD	Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainreader ApS. Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Health . Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Neurevolution Medicine.
Faisal Amin, MD, PhD	Dr. Amin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Amin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Amin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Amin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Amin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Amin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Amin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Amin has received research support from Rigshospitalet.
Antonio Gallo	Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis.
Gerolama Marfia	No disclosure on file
Giovanna De Luca	No disclosure on file
Joseph J. Sabatino, Jr., MD	The institution of Dr. Sabatino has received research support from Roche/Genentech.
Katelyn S. Kavak	Ms. Kavak has nothing to disclose.
Laura M. Scorr, MD	Dr. Scorr has received research support from Dystonia Medical Research Foundation.
Christopher D. Stephen, MB ChB, FRCP, MSc, SM	The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Shyamal Mehta, MD, PhD, FAAN	Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharma. Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CNS Ratings.
Sameer Sharma, MD, MBBS	Dr. Sharma has nothing to disclose.
Maria Vassilaki, MD, PhD	Dr. Vassilaki has stock in Abbott Laboratories. Dr. Vassilaki has stock in Johnson and Johnson. Dr. Vassilaki has stock in Medtronic. Dr. Vassilaki has stock in Amgen. Dr. Vassilaki has stock in AbbVie. Dr. Vassilaki has stock in Merck. The institution of Dr. Vassilaki has received research support from NIH. The institution of Dr. Vassilaki has received research support from European Union/ St. Anne's University Hospital Brno, Czech Republic. The institution of an immediate family member of Dr. Vassilaki has received research support from Avobis Bio, LLC.
Hsiangkuo Yuan, MD, PhD	An immediate family member of Dr. Yuan has received personal compensation for serving as an employee of Merck. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Salvia. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovous. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Regional Anesthesia and Pain Medicine. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Headache and Pain Reports. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. The institution of Dr. Yuan has received research support from NIH. The institution of Dr. Yuan has received research support from American Headache Society. The institution of Dr. Yuan has received research support from Pfizer. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Invited speaker with Chinese Stroke Association.
DeWitt D. Pyburn, MD	Dr. Pyburn has nothing to disclose.
Michael J. Hennessy	Michael J. Hennessy has nothing to disclose.
Seyed A. Fatemi, MD, MBA	Dr. Fatemi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for RCO law. The institution of Dr. Fatemi has received research support from Minoryx. The institution of Dr. Fatemi has received research support from Viking Therapeutics. The institution of Dr. Fatemi has received research support from Swanbio Therapeutics . The institution of Dr. Fatemi has received research support from Autobahn Therapeutics. The institution of Dr. Fatemi has received research support from Nuvelution. The institution of Dr. Fatemi has received research support from NIH. The institution of Dr. Fatemi has received research support from A Cure for Ellie Foundation. The institution of Dr. Fatemi has received research support from Brian's Hope Foundation . Dr. Fatemi has received intellectual property interests from a discovery or technology relating to health care. Dr. Fatemi has a non-compensated relationship as a Director (Board member) with ALDConnect that is relevant to AAN interests or activities.
Jessica Ailani, MD, FAAN	Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspya. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kallyope. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. The institution of Dr. Ailani has received research support from Merz. The institution of Dr. Ailani has received research support from Pfizer. Dr. Ailani has received research support from Mi-Helper. The institution of Dr. Ailani has received research support from ShiraTronic. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities.
Sarah Hopkins, MD	The institution of Dr. Hopkins has received research support from NIH. The institution of Dr. Hopkins has received research support from CDC.
Leslie Leahy, PhD	Dr. Leahy has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Vigil Neuroscience. Dr. Leahy has stock in Ovid Therapeutics.
Adam S. Jasne, MD	Dr. Jasne has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Robert W. Regenhardt, MD, PhD	Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.
Danielle S. Shpiner, MD	An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
Lidia Maria V. Moura, MD, PhD, MPH, FAAN	Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Moura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America . The institution of Dr. Moura has received research support from NIH - NIA and NINDS. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Advisor with Epilepsy Foundation .
Mitra Afshari, MD	Dr. Afshari has received research support from Consolidated Anti-Aging Foundation . Dr. Afshari has received research support from Parkinson Study Group.
Nicolas J. Abreu, MD	Dr. Abreu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Abreu has received research support from Adult Polyglucosan Body Disease Research Foundation. The institution of Dr. Abreu has received research support from Sanofi Genzyme. The institution of Dr. Abreu has received research support from Takeda. The institution of Dr. Abreu has received research support from Sangamo. The institution of Dr. Abreu has received research support from BDSRA Foundation.
Jessica Magid-Bernstein, MD, PhD	Dr. Magid-Bernstein has nothing to disclose.
Janina Krell-Roesch, PhD	Dr. Krell-Roesch has nothing to disclose.
Robin L. Avila, PhD	Mrs. Avila has received personal compensation for serving as an employee of Biogen. Mrs. Avila has stock in Biogen.
Hisham Salahuddin, MD	Dr. Salahuddin has nothing to disclose.
Samar F. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Mackenzie A. Michell-Robinson, MSc	Mackenzie A. Michell-Robinson has nothing to disclose.
Omar Basha, MD	Dr. Basha has nothing to disclose.
Atul T. Patel	Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IPSEN. Atul T. Patel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for IPSEN. The institution of Atul T. Patel has received research support from Abbvie. The institution of Atul T. Patel has received research support from IPSEN.
Rodrigo Hasbun	Rodrigo Hasbun has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biomeriaux. The institution of Rodrigo Hasbun has received research support from Biomeriaux.
Rodolphe Nenert	Rodolphe Nenert has nothing to disclose.
Karla A. Mora-Rodriguez, MD	Dr. Mora-Rodriguez has nothing to disclose.
Aleksandra Yakhkind, MD	Dr. Yakhkind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LangAware. Dr. Yakhkind has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Yakhkind has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Round Table Group. Dr. Yakhkind has received research support from Sara's Wish Foundation Global Health Grant. Dr. Yakhkind has received publishing royalties from a publication relating to health care. Dr. Yakhkind has a non-compensated relationship as a Faculty with Massachusetts General Hospital CME that is relevant to AAN interests or activities.
Marc Kamin, MD	Dr. Kamin has received personal compensation for serving as an employee of SK LIFE SCIENCE INC.
Jessica Zwerling, MD, FAAN	Dr. Zwerling has nothing to disclose.
Timothy Cunniff, PharmD	Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences.
Lisa T. Emrick, MD	Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.
Timothy Leichliter, MD	Dr. Leichliter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine.
David Lin, MD	Dr. Lin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurotrauma Sciences. Dr. Lin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blue Rock Therapeutics. Dr. Lin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IoTA Biosciences. Dr. Lin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Lin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Encompass Health. Dr. Lin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Best in Class MD.
Leslie E. Perry Grayson, MD	Dr. Perry Grayson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals . The institution of Dr. Perry Grayson has received research support from Department of Defense .
Tyler E. Gaston, MD	Dr. Gaston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. The institution of Dr. Gaston has received research support from NINDS.
Jason H. Margolesky, MD, FAAN	Dr. Margolesky has nothing to disclose.
Muhammad-Atif Zubairi, MD	Dr. Zubairi has nothing to disclose.
Lenora A. Higginbotham, MD	The institution of Dr. Higginbotham has received research support from NIH/NINDS . The institution of Dr. Higginbotham has received research support from Bright Focus Foundation. The institution of Dr. Higginbotham has received research support from American Academy of Neurology. Dr. Higginbotham has received intellectual property interests from a discovery or technology relating to health care.
Alain Z. Lekoubou Looti, MD	Dr. Lekoubou Looti has nothing to disclose.
Jamie LaBuzetta, MD	Dr. LaBuzetta has nothing to disclose.
Stacy C. Brown, MD	Dr. Brown has nothing to disclose.
Fatemah Alshawaf, MD	Dr. Alshawaf has nothing to disclose.
Fawad Yousuf, MBBS	Dr. Yousuf has nothing to disclose.
Lucinda L. Hugos, PT	Ms. Hugos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. Ms. Hugos has received personal compensation in the range of $0-$499 for serving as a Consultant for Evidera, Inc.. Ms. Hugos has received personal compensation in the range of $0-$499 for serving as a Consultant for Techspert.io Ltd.. Ms. Hugos has received research support from Portland VA. Ms. Hugos has received research support from Oregon Health & Science University. Ms. Hugos has received research support from Oregon Health & Science University. Ms. Hugos has received publishing royalties from a publication relating to health care.
Walter Kremers	The institution of Walter Kremers has received research support from NIH. The institution of an immediate family member of Walter Kremers has received research support from NIH.
Monica Margoni	Monica Margoni has received research support from MAGNIMS. Monica Margoni has received research support from Merck-Serono. Monica Margoni has received research support from Sanofi-Genzyme.
Daniel Moreno-Zambrano, MD	Dr. Moreno-Zambrano has nothing to disclose.
Astrid Scheschonka	No disclosure on file
Jeremy Syrjanen	Jeremy Syrjanen has nothing to disclose.
Stephen Wanaski, PhD	Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has or had stock in Paragon Biosciences.Dr. Wanaski has or had stock in Emalex Biosciences.
Jorg Wissel	No disclosure on file
Luca Bartolini, MD, FAAN	Dr. Bartolini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. Dr. Bartolini has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology.
Peter Feys	Peter Feys has nothing to disclose.
Michael Althaus	Michael Althaus has received personal compensation for serving as an employee of Merz Pharmaceuticals.
Vishwanath Sagi, MD, FAAN	Dr. Sagi has nothing to disclose.
Diana P. Londono, MD	Dr. Londono has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Davide Martino, MD, PhD	Dr. Martino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Martino has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merz Pharma Canada Ltd..
Anoopum Gupta, MD, PhD	Dr. Gupta has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biogen. The institution of Dr. Gupta has received research support from Biogen.
Ning Su, MD	Dr. Su has nothing to disclose.
Lixin Zhou	Lixin Zhou has nothing to disclose.
Anjali Gera, MD	Dr. Gera has nothing to disclose.
Melvin Parasram, DO	Dr. Parasram has nothing to disclose.
Sahyli Perez Parra, MD	Dr. Perez Parra has nothing to disclose.
Subin Mathew, MD, FAAN	Dr. Mathew has nothing to disclose.
Andrea Hildebrand	The institution of Ms. Hildebrand has received research support from National MS Society.
Marco Alfonso Narduc Capobianco	Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Gabriel D. Pinilla Monsalve, MD, MSc	Dr. Pinilla Monsalve has nothing to disclose.
Matthew Broderick, MD	Dr. Broderick has nothing to disclose.
Harry Sutherland, MD	Dr. Sutherland has received publishing royalties from a publication relating to health care.
Michelle Offit, MD, MS	No disclosure on file
Fang-Chi Hsu	No disclosure on file
Markus D. Schirmer, PhD	The institution of Dr. Schirmer has received research support from National Institute of Aging.
Fei Han	Fei Han has nothing to disclose.
Zheng-Yu Jin	No disclosure on file
Shaweta Khosa	Ms. Khosa has nothing to disclose.
Jun Ni	Jun Ni has nothing to disclose.
Ming Yao	Ming Yao has nothing to disclose.
Shu-Yang Zhang	No disclosure on file
Maegan Newell, MD	Dr. Newell has nothing to disclose.
Aleksej Zuzek, PhD	Dr. Zuzek has received personal compensation for serving as an employee of AbbVie Inc.. Dr. Zuzek has stock in AbbVie Inc..
Eugene Schneider, MD	Dr. Schneider has received personal compensation for serving as an employee of ionis pharmaceuticals.
Somayeh Meysami, MD	Dr. Meysami has nothing to disclose.
Verna R. Porter, MD, FAAN	Dr. Porter has nothing to disclose.
Justin A. Salerian, MD	Dr. Salerian has nothing to disclose.
Sushma Kola, MD	Dr. Kola has nothing to disclose.
Adreesh Mukherjee, MD	Dr. Mukherjee has nothing to disclose.
Michael Hast	Michael Hast has received personal compensation for serving as an employee of Merz Therapeutics.
Elias Samaha, MD	Dr. Samaha has nothing to disclose.
Nessim Amin, MD	Dr. Amin has nothing to disclose.
Nikita Shukla, MD	The institution of Dr. Shukla has received research support from Roche.
Sorleen Trevino, MD	Dr. Trevino has nothing to disclose.
Ding-Ding Zhang	Ding-Ding Zhang has nothing to disclose.
Eoin Finegan, MBBS	Dr. Finegan has nothing to disclose.
Tobias Sejbaek, MD, PhD	Prof. Sejbaek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Merck, NeuroXpharm, Novartis, Roche, Sandoz and Sanofi. The institution of Prof. Sejbaek has received research support from Merck, Novartis, Roche and Sanofi.
Shemonti Hasan, MD	Dr. Hasan has nothing to disclose.
Sarah Marmol, MD	Dr. Marmol has nothing to disclose.
Danielle Larson, MD	Dr. Larson has received personal compensation in the range of $0-$499 for serving as a Consultant for Acadia Pharmaceuticals.
Edwin N. Peguero, MD	Dr. Peguero has nothing to disclose.
Kenneth P. Martinez, MD	The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. The institution of Dr. Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Martinez has received research support from Medtronic. The institution of Dr. Martinez has received research support from Abbvie/Allergan.
Patricia Pozo-Rosich, MD, PhD	Dr. Pozo-Rosich has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pozo-Rosich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Organon. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr. Reddy's. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sociedad Española Neurologia.
Richa Sharma, MD	Dr. Sharma has received research support from NIH. Dr. Sharma has received intellectual property interests from a discovery or technology relating to health care.
Giampaolo Brichetto, MD, PhD	Giampaolo Brichetto, MD, PhD has received personal compensation for serving as an employee of Italian MS Society.
Katherine A. Zarroli, MD	Dr. Zarroli has nothing to disclose.
Teng J. Peng, MD	Dr. Peng has nothing to disclose.
Cameron Mohammadi, MD	Dr. Mohammadi has nothing to disclose.
Bela Turk, MD	Dr. Turk has received intellectual property interests from a discovery or technology relating to health care. Dr. Turk has received publishing royalties from a publication relating to health care.
Sutapa Ray, PhD	Dr. Ray has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Ray has stock in Impel Pharmaceuticals.
Lee E. Neilson, MD	Dr. Neilson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hart Wagner LLP. Dr. Neilson has received research support from VA ORD - Clinical Science Research and Development. An immediate family member of Dr. Neilson has received research support from NIH - NINDS.
Nicholas S. Streicher, MD	Dr. Streicher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Streicher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovent. Dr. Streicher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Streicher has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Streicher has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion.
Majed Alzahrany, MBBS	Dr. Alzahrany has nothing to disclose.
Ahmed Abd Elazim, MD	Dr. Abd Elazim has nothing to disclose.
Louis Ferrari	Louis Ferrari has received personal compensation for serving as an employee of SK Life science.
Rashid A. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Joyce A. Jimenez Zambrano, MD	Dr. Jimenez Zambrano has nothing to disclose.
Chirag L. Patel, MD, PhD	Dr. Patel has nothing to disclose.
Enrique Gomez Figueroa, MD, MSc	Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson LATAM.
Bassil Kherallah, MD	Dr. Kherallah has nothing to disclose.
Kiley Cameron, MD	Dr. Cameron has nothing to disclose.
Huanwen Chen, MD	Dr. Chen has nothing to disclose.
Neha Verma	No disclosure on file
Jacklyn Johnson, MD	Dr. Johnson has nothing to disclose.
Gilbert J. L'Italien	Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Lucas S. Silva, MD	Dr. Silva has nothing to disclose.
Christopher Jensen, PharmD	Dr. Jensen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Jensen has stock in Biohaven Pharmaceuticals.
Robert Croop, MD	Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has received personal compensation for serving as an employee of Pfizer Inc.. Dr. Croop has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Collima LLC. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has stock in Biohaven Ltd.. Dr. Croop has stock in Actio Biosciences, Inc. . Dr. Croop has received research support from Pfizer Inc. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
Sarah Stoney, MSW, LSW	Sarah Stoney, MSW, LSW has received personal compensation in the range of $0-$499 for serving as a Consultant for Muscular Dystrophy Association. Sarah Stoney, MSW, LSW has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Sarah Stoney, MSW, LSW has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. Sarah Stoney, MSW, LSW has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Sarah Stoney, MSW, LSW has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC .
Swetha Vennavaram, MD	Dr. Vennavaram has nothing to disclose.
Anna Kafka, DO	Dr. Kafka has nothing to disclose.
Jeffrey Neul, MD, PhD	Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. Dr. Neul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group. Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Neul has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alcyone. Dr. Neul has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid. Dr. Neul has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Neul has stock in LizardBio. The institution of Dr. Neul has received research support from NIH. The institution of Dr. Neul has received research support from Acadia. The institution of Dr. Neul has received research support from GW Pharmaceuticals. The institution of Dr. Neul has received research support from International Rett Syndrome Foundation. The institution of Dr. Neul has received research support from Rett Syndrome Research Trust.
Louis Goodrich, DO	Dr. Goodrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono.
John M. Picard, MD	Dr. Picard has nothing to disclose.
Daniel Davila-Williams, MD	Dr. Davila-Williams has nothing to disclose.
Kaleb L. Culpepper, DO	Dr. Culpepper has nothing to disclose.
Vivek Satyasi, MD	Dr. Satyasi has nothing to disclose.
Dina Namiranian, MD	Dr. Namiranian has nothing to disclose.
Miryam Alkayyali, MD	Dr. Alkayyali has nothing to disclose.
Nicholas Viney	Nicholas Viney has received personal compensation for serving as an employee of Ionis Pharmaceuticals Inc.. Nicholas Viney has stock in Ionis Pharmaceuticals. Nicholas Viney has received intellectual property interests from a discovery or technology relating to health care.
Nicolo Bruschi	Mr. Bruschi has nothing to disclose.
Agustin Melo Carrillo, MD, PhD	Dr. Melo Carrillo has nothing to disclose.
Ross Reichard	Ross Reichard has nothing to disclose.
Hamza Coban, MD	Dr. Coban has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono.
Elle Levit, MD	Dr. Levit has nothing to disclose.
Sindhu Reddy Pisati, MD, MBBS	Dr. Pisati has nothing to disclose.
Hideo Kihara	Hideo Kihara has nothing to disclose.
Victoria Hodgkinson	No disclosure on file
Yi Dai	No disclosure on file
Jorge Jacinto	Jorge Jacinto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz, Ipsen, Allergan. Jorge Jacinto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz, Allergan, Ipsen.
Mirja Koch	Mirja Koch has received personal compensation for serving as an employee of Novartis.
Stephen Ashford	Stephen Ashford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Stephen Ashford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Stephen Ashford has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. The institution of Stephen Ashford has received research support from Ipsen.
Carmen Vizzino	No disclosure on file
Feifei Zhai	No disclosure on file
Luis G. Manrique, MD	Dr. Manrique has nothing to disclose.
Daniel Zhou, MD	The institution of Dr. Zhou has received research support from American Epilepsy Society. The institution of Dr. Zhou has received research support from National Institutes of Health.
Juan Pablo Fernandez, MD	Dr. Fernandez has nothing to disclose.
Jerry Hall	Jerry Hall has received personal compensation for serving as an employee of Eli Lilly & Co.. Jerry Hall has stock in Eli Lilly & Co..
Pranav Gandhi	Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
Lauren A. Terpak, MD	Dr. Terpak has nothing to disclose.
Avi Landman, MD	Dr. Landman has nothing to disclose.
Isha Snehal, MBBS	Dr. Snehal has nothing to disclose.
Sigmund Lilian, MD	Dr. Lilian has nothing to disclose.
Sidra Saleem, MD	Dr. Saleem has nothing to disclose.
Jennifer Hislop, MD	Dr. Hislop has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Veterans Affairs.
Andrea R. Lowden, MD	Dr. Lowden has nothing to disclose.
Mariana Nelson, PhD	Dr. Nelson has received personal compensation for serving as an employee of AbbVie. Dr. Nelson has stock in AbbVie Inc.
Brett Dabruzzo, PharmD	Dr. Dabruzzo has received personal compensation for serving as an employee of AbbVie. Dr. Dabruzzo has stock in AbbVie.
Sarah Germaine, DO	Dr. Germaine has nothing to disclose.
Victor Wang, MD	Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Melody T. Asukile, MBBS	Dr. Asukile has received research support from Royal Society for Tropical Medicine and Hygiene. The institution of Dr. Asukile has received research support from Leverhulme Trust. Dr. Asukile has received personal compensation in the range of $0-$499 for serving as a meeting speaker with American Neurological Association.
Sumayya Naz, MD	Dr. Naz has nothing to disclose.
Sadia Waheed, MBBS	Dr. Waheed has nothing to disclose.
Keyvan Heshmati, MD	Dr. Heshmati has nothing to disclose.
Eric R. Wong, DO	Dr. Wong has nothing to disclose.
Catherine Boldig, DO	Dr. Boldig has nothing to disclose.
Frighton B. Mutete, MBChB	Dr. Mutete has nothing to disclose.
Hira Pervez, MD, MBBS	Dr. Pervez has nothing to disclose.
Natalia Szejko, MD, PhD	Dr. Szejko has nothing to disclose.
Damiano Mistri, MSC	Mr. Mistri has nothing to disclose.
Carole Drexel	Carole Drexel has nothing to disclose.
Naluca Mwendaweli, MMED	NALUCA MWENDAWELI has nothing to disclose.
Eileen Sawyer, PhD	Eileen Sawyer has received personal compensation for serving as an employee of uniQure Inc. Eileen Sawyer has received stock or an ownership interest from uniQure Inc.
Aman Patel	Aman Patel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Microvention. Aman Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Aman Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Aman Patel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Penumbra.
Samiksha Srivastava, MD	Dr. Srivastava has nothing to disclose.
Jing Yuan	No disclosure on file
Maurice Driessen	No disclosure on file
Michael Young, MD	The institution of Dr. Young has received research support from NIH/NINDS. The institution of Dr. Young has received research support from Department of Defense. The institution of Dr. Young has received research support from Chen Institute.
Judy Liu, MD, PhD	The institution of Dr. Liu has received research support from NIH/NINDS.
Linda A. Piccinini, PhD	An immediate family member of Dr. Piccinini has received personal compensation for serving as an employee of Biogen. Dr. Piccinini has received stock or an ownership interest from Biogen.
Rita Singh, PharmD	Dr. Singh has received personal compensation for serving as an employee of AbbVie. Dr. Singh has stock in AbbVie.
Katherine M. Harris, MD	Dr. Harris has nothing to disclose.
Amanda M. Nagy, MD	Dr. Nagy has nothing to disclose.
Robert Vann, PhD	Dr. Vann has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Vann has received personal compensation for serving as an employee of Biogen.
Ann N. Ly, MD	Dr. Ly has nothing to disclose.
Angela Pontius	Mrs. Pontius has received personal compensation for serving as an employee of Vigil Neuroscience, Inc.
Leo Coutinho, MD	Dr. Coutinho has nothing to disclose.
Harinoor Mann, MBBS	Dr. Mann has nothing to disclose.
Hasmik Amirjanyan, MD	Dr. Amirjanyan has nothing to disclose.
Deema Sawass Najjar, MD	Dr. Sawass Najjar has nothing to disclose.
Christian A. Sam, MD	Dr. Sam has nothing to disclose.
Valeria Ariza Hutchinson, MD	Dr. Ariza Hutchinson has nothing to disclose.
Khaled Gharaibeh, MD	Dr. Gharaibeh has nothing to disclose.
Muhammad Aemaz Ur Rehman, MD	Dr. Aemaz Ur Rehman has nothing to disclose.
Shirin Jamal Omidi, MD	Dr. Jamal Omidi has nothing to disclose.
Sofia Ramirez Guerrero, MD	Dr. Ramirez Guerrero has nothing to disclose.
Emily Casaletto	Miss Casaletto has nothing to disclose.
Shruthi Venkatesh	Miss Venkatesh has received research support from NIH.
Octavio Carranza-Renteria, MD	Dr. Carranza-Renteria has nothing to disclose.
Nishika Karbhari, MD	Dr. Karbhari has nothing to disclose.
Sayyeda Zahra, MD	Dr. Zahra has nothing to disclose.
Raissa Aoun, MD	Dr. Aoun has nothing to disclose.
Claudia Talero-Gutierrez	Dr. Talero-Gutierrez has nothing to disclose.
Abdulrahman I. Hagrass, MBBS	Mr. Hagrass has nothing to disclose.
Adam Dmytriw	Adam Dmytriw has nothing to disclose.
John Curran	Mr. Curran has nothing to disclose.
Mohamed S. Zaazouee	Mr. Zaazouee has nothing to disclose.
Justin Vranic	No disclosure on file
Christopher Stapleton	Christopher Stapleton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson & Johnson MedTech. Christopher Stapleton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll Circulation, Inc.. Christopher Stapleton has received publishing royalties from a publication relating to health care.
Marie Groth, PhD	Dr. Groth has received personal compensation for serving as an employee of Novartis Pharma GmbH.
Rebecca Merrill, MD	Ms. Merrill has nothing to disclose.
Katherine E. Beard, MD	Miss Beard has nothing to disclose.
Anna K. Bonkhoff, MD	Dr. Bonkhoff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeuroImage Clinical (Elsevier).
Damian M. May, Other	Dr. May has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. May has stock in ACADIA Pharmaceuticals. Dr. May has stock in Medtronic. Dr. May has stock in Johnson & Johnson. Dr. May has stock in Pfizer Pharmaceuticals.
John Waters	Mr. Waters has nothing to disclose.
Jiayuan Liu	Ms. Liu has nothing to disclose.
Andrea Hernandez	Ms. Hernandez has nothing to disclose.
Christopher P. Rhyne, MD	Dr. Rhyne has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Rhyne has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie/Allergan. Dr. Rhyne has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie/Allergan. Dr. Rhyne has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck.
Cyprien Rivier, MD	Dr. Rivier has nothing to disclose.
Charly Gaul	The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of an immediate family member of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vectura. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Charly Gaul has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dr. Reddy. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Perfood. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reckitt-Benckiser . The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hormosan. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chordate. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Dr. Reddy. The institution of Charly Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Kimberly Ifantides	Kimberly Ifantides has received personal compensation for serving as an employee of AbbVie. Kimberly Ifantides has stock in Abbvie.
Atul Mahableshwarkar	Atul Mahableshwarkar has received personal compensation for serving as an employee of Emalex Biosciences. Atul Mahableshwarkar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ecor1 Capital. Atul Mahableshwarkar has stock in Johnson & Johnson.
Nancy Lynn, Other	Ms. Lynn has nothing to disclose.
Matthew Feldman, MD	Dr. Feldman has nothing to disclose.
Mohamed Darwish, MD	Dr. Darwish has nothing to disclose.
Jennifer R. Shaw	Ms. Shaw has nothing to disclose.
Varun Kannan, MD	Dr. Kannan has nothing to disclose.
Matthew Roberts, MD	Dr. Roberts has nothing to disclose.
M. Samy Abdullah, MD	Dr. Abdullah has nothing to disclose.
Aline F. Dias, MD, Other	Miss Dias has received research support from CAPES. Miss Dias has received research support from FAPESP.
Christelle Nilles, MD	Dr. Nilles has received research support from French Gilles de la Tourette Association. Dr. Nilles has received research support from Owerko Centre of Alberta Children's Hospital Research Institute.
Connor Bluntson, MD	Mr. Bluntson has nothing to disclose.
Paul Dorman, MD	The institution of Dr. Dorman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Dorman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Dorman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Juan Appendino, MD	Dr. Appendino has nothing to disclose.
Chinasa Nwankwo, MD, FAAN	Dr. Nwankwo has nothing to disclose.
Marjan Sadeghi, PharmD	Dr. Sadeghi has received personal compensation for serving as an employee of AbbVie. Dr. Sadeghi has stock in Abbvie.
Kamilla Ostergaard, MD	Dr. Ostergaard has nothing to disclose.
Rebekah G. Torres, NP	Mrs. Torres has received personal compensation in the range of $0-$499 for serving as a Panelist with IQVIA.
Brad Torphy	Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome. Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. Brad Torphy has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Abbvie. The institution of Brad Torphy has received research support from Abbvie. The institution of Brad Torphy has received research support from Teva. The institution of Brad Torphy has received research support from Lilly. The institution of Brad Torphy has received research support from Pfizer.
David Bendetowicz	The institution of Mr. Bendetowicz has received research support from Fondation Recherche Médicale.
Pamela K. Cheng, DO	Dr. Cheng has nothing to disclose.
Peter W. Campbell, MD, PhD	Dr. Campbell has nothing to disclose.
Tianrong Yeo, MBBS	The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving as a Consultant for Edanz Pharma. The institution of Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis . The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Terumo BCT. The institution of Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Euroimmun AG . The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis . The institution of Dr. Yeo has received research support from National Medical Research Council (Singapore) . The institution of Dr. Yeo has received research support from Roche .
Alex K. Verma, MD	Dr. Verma has nothing to disclose.
Randall Brown, MD, MS	Dr. Brown has nothing to disclose.
Sheena Baratono, MD, PhD	Dr. Baratono has stock in moderna.
Brett Downing	Mr. Downing has received personal compensation for serving as an employee of Impel Pharmaceuticals .
Muhammad I. Yousaf, MD	Dr. Yousaf has nothing to disclose.
Courtney Venegas, MD	Dr. Venegas has nothing to disclose.
Samuel Durojaye, MD	Dr. Durojaye has nothing to disclose.
Cristina Tassorelli	Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Cristina Tassorelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Organon. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Cristina Tassorelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Cristina Tassorelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Organon. Cristina Tassorelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva . The institution of Cristina Tassorelli has received research support from Abbvie.
Daniella L. Fonseca, NP	Ms. Fonseca has received personal compensation for serving as an employee of Impel Pharmaceuticals. Ms. Fonseca has stock in Impel Pharmaceuticals.
Jaudat Masood, MD	Dr. Masood has nothing to disclose.
Alexander Andreev, MD	Dr. Andreev has nothing to disclose.
Kirsten Sjonnesen, MD	Dr. Sjonnesen has nothing to disclose.
Christine Gummerson, MD	Dr. Gummerson has received personal compensation in the range of $0-$499 for serving as a NeuroBytes faculty contributor with American Academy of Neurology.
Laura Naydovich, MD	Dr. Wolf has nothing to disclose.
Brahyan Galindo Mendez, MD, MPH	Dr. Galindo Mendez has nothing to disclose.
Rikka Azuma, MD	Dr. Azuma has nothing to disclose.
Andrew Thaliath, MBBS	Dr. Thaliath has nothing to disclose.
Radostina Iordanova, DO	Dr. Iordanova has nothing to disclose.
Qiu Zi Yang, MD	Dr. Yang has nothing to disclose.
Krystian Solis, MD	Dr. Solis has nothing to disclose.
Niveta Aravind, MD	Dr. Aravind has nothing to disclose.
Akm Muktadir, MD	Dr. Muktadir has nothing to disclose.
Zachary Hodosevich, MD	Dr. Hodosevich has nothing to disclose.
Shadi Shams, MD	Dr. Shams has nothing to disclose.
Natty Chalermpalanupap, PhD	Dr. Chalermpalanupap has received personal compensation for serving as an employee of AbbVie. Dr. Chalermpalanupap has stock in AbbVie.
Mustafa Al Gburi, MD	Dr. Al Gburi has nothing to disclose.
Valentina Velasco	Miss Velasco has nothing to disclose.
Alexander Ankar, MD	Dr. Ankar has nothing to disclose.
Jonathan Yarimi, MD	Dr. Yarimi has nothing to disclose.
Zheming Yu, MD	Dr. Yu has nothing to disclose.
Talita D'Aguiar Rosa, MD	Dr. D'Aguiar Rosa has nothing to disclose.
Mustafa Mohamed, MD	Dr. Mohamed has nothing to disclose.
Poojith Nuthalapati, MD	Mr. Nuthalapati has nothing to disclose.
Manik Tetarbe, MD	Dr. Tetarbe has nothing to disclose.
Joo Won Choi, MD	Mr. Choi has nothing to disclose.
Shashi K. Maryala, MBBS	Dr. Maryala has nothing to disclose.
Syed Y. Shah, MD	Dr. Shah has nothing to disclose.
Fiza K. Laheji, MBBS	Dr. Laheji has nothing to disclose.
Carlos E. Garcia Ocasio	Dr. Garcia Ocasio has nothing to disclose.
Amine Mohamed Marc Awad, BM BCh	Dr. Awad has nothing to disclose.
Sakina Batool	Miss Batool has nothing to disclose.
Joao Vitor Mahler, MD	Dr. Mahler has received research support from The Sumaira Foundation.
Aya N. Shnawa, MD	Dr. Shnawa has nothing to disclose.
Marina Solti, MD	Dr. Solti has nothing to disclose.
Adriana Ochoa, MD	Dr. Ochoa has nothing to disclose.
Timothy Lee, MD	Dr. Lee has nothing to disclose.
Nbaa Masood, MD	Dr. Masood has nothing to disclose.
Louise M. McCarthy, MB BCh BAO	Dr. McCarthy has nothing to disclose.
Juan P. Cabrera Pulla, MD	Dr. Cabrera Pulla has nothing to disclose.
Uddalak Chakraborty, MD, MBBS	Dr. Chakraborty has nothing to disclose.
Avinash S. Kolli, MD	Dr. Kolli has nothing to disclose.
Marc Daou, MD	Dr. Daou has nothing to disclose.
Ivanna Joseph, MD	Dr. Joseph has nothing to disclose.
Gayatri Raj Ghosh, MD	Dr. Raj Ghosh has nothing to disclose.
Cate D. Picou, DO	Dr. Picou has nothing to disclose.
Gitanjali Das, MD	Dr. Das has nothing to disclose.
Juan C. Ayala Alvarez, MD	Dr. Ayala Alvarez has nothing to disclose.
Georg Comes	Georg Comes has received personal compensation for serving as an employee of Merz Therapeutics GmbH.
Manouchehr Amanat Yazdi, MD	Dr. Amanat Yazdi has nothing to disclose.
Adel Hijazi, MD	Mr. Hijazi has nothing to disclose.
Susie Sinks	No disclosure on file
Sahil S. Suvarna, DO	Dr. Suvarna has nothing to disclose.
Manmeet S. Sahni	Mr. Sahni has nothing to disclose.
Nicole Sukkarieh, MD	Dr. Sukkarieh has nothing to disclose.
Juliana Stoilova, MD	Ms. Stoilova has nothing to disclose.
Naman Bareja, MBBS	Dr. Bareja has nothing to disclose.
Tyra Gatewood	Ms. Gatewood has nothing to disclose.
Alexia Duarte, MD	Miss Duarte has nothing to disclose.
Nicholas Schuck, MD	Dr. Schuck has nothing to disclose.
Manasa Sudheendra, MBBS	Dr. Sudheendra has nothing to disclose.
Murad Al-Nusaif	Dr. Al-Nusaif has nothing to disclose.
Jose F. Ortega Tola, MD	Dr. Ortega Tola has nothing to disclose.
Elmira M. Veselinovic, MD	Dr. Veselinovic has nothing to disclose.
Philip T. Kuball, MD	Dr. Kuball has nothing to disclose.
Amena S. Fine, MD, PhD	The institution of Dr. Fine has received research support from NIH.
Ivan Roque Sanchez, MD	Dr. Roque Sanchez has nothing to disclose.
Ian J. Kinney	Mr. Kinney has nothing to disclose.
Andrea Mendez Colmenares, MD, PhD	Dr. Mendez Colmenares has nothing to disclose.
Sailaja Sanikommu, MBBS	Dr. Sanikommu has nothing to disclose.
Ammar Aljabri, Jr.	Mr. Aljabri has nothing to disclose.
Omar Alageely	Mr. Alageely has nothing to disclose.
Kanika Sharma	Ms. Sharma has nothing to disclose.
Michael E. Limia, MD	Mr. Limia has nothing to disclose.
Pukhraj Nijhar	Mr. Nijhar has nothing to disclose.
Kunal Debroy, MD	Dr. Debroy has nothing to disclose.
Jacob Arkin	Mr. Arkin has nothing to disclose.
Kamleshun Ramphul	Kamleshun Ramphul has nothing to disclose.
Renuka Verma	Renuka Verma has nothing to disclose.
Brendan Colgan, MD	Mr. Colgan has nothing to disclose.
Shaheen Sombans, MBBS	Dr. Sombans has nothing to disclose.
Kelsey Beck, MD	Miss Beck has nothing to disclose.
Yingyi Liu	Yingyi Liu has received personal compensation for serving as an employee of AbbVie.
Gengshi Chen	Mrs. Chen has received personal compensation for serving as an employee of AstraZeneca. Mrs. Chen has stock in AstraZeneca.
Cordula Weiss, PhD	Dr. Weiss has received personal compensation for serving as an employee of Novartis Pharma GmbH.
Francesco Romano	Francesco Romano has nothing to disclose.
Tetsu Morozumi, PT	Mr. Morozumi has nothing to disclose.
Ahunna Ukah	Ahunna Ukah has received personal compensation for serving as an employee of AbbVie. Ahunna Ukah has stock in AbbVie.
Se Hee Jung, MD, PhD	The institution of Prof. Jung has received research support from National Rehabilitation Center, Ministry of Health and Welfare, South Korea.
Abida P. Babu, MD, MBBS	Dr. Babu has nothing to disclose.
Fahham Asghar, MD	Mr. Asghar has nothing to disclose.
Andra-Ecaterina Boca	No disclosure on file
David Borsook	No disclosure on file
Emma McFadden, PhD	Dr. McFadden has nothing to disclose.
Wenxin Li	Mrs. Li has nothing to disclose.
Jay Shah, MD	Mr. Shah has nothing to disclose.
Jersey Chen, MD	Dr. Chen has received personal compensation for serving as an employee of AstraZeneca. Dr. Chen has stock in AstraZeneca.
Christian Hannes	Dr. Hannes has received personal compensation for serving as an employee of Ipsen. Dr. Hannes has stock in Ipsen.
Daniele Urso, MD	Dr. Urso has nothing to disclose.
Agnese Mascolo	No disclosure on file
Oralee J. Varnado, PhD	Miss Varnado has received personal compensation for serving as an employee of Eli Lilly and Company. Miss Varnado has stock in Eli Lilly and Company.
Sarah E. Bellatti	Ms. Bellatti has nothing to disclose.
Danilo A. Peralta	Mr. Peralta has nothing to disclose.
Teresa Wu	Teresa Wu has nothing to disclose.
Angelica G. Montilla	Miss Montilla has nothing to disclose.
Bhaswar Bhattacharya, Jr.	Dr. Bhattacharya has nothing to disclose.
Brian Sandroff	The institution of Brian Sandroff has received research support from NIH, NIDILRR, National MS Society.
Cecilia Meza	Cecilia Meza has nothing to disclose.
Stephen Manu, MD	Dr. Manu has nothing to disclose.
Julia Macintosh, Other	Ms. Macintosh has nothing to disclose.
Hanah A. Imam, MBBS	Dr. Imam has nothing to disclose.
Ali Haider Bangash	Mr. Bangash has nothing to disclose.
Frederik Novak, MD	Dr. Novak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi A/S.
Michael Thomas	No disclosure on file
William Drew	Mr. Drew has nothing to disclose.
Jin Yun Helen Chen, MS, LCGC	Ms. Chen has nothing to disclose.
Mingyu Tang	Mingyu Tang has nothing to disclose.
Emma Krening, Other	Ms. Krening has nothing to disclose.
Victoria Q. Tay	Miss Tay has nothing to disclose.
Jennifer Freeman	Jennifer Freeman has nothing to disclose.
Yolanda Pina	No disclosure on file
Dean Spurden, PhD	Dr. Spurden has received personal compensation for serving as an employee of IPSEN.
Adarsh Mavathaveedu	Mr. Mavathaveedu has nothing to disclose.
Margaret Hoyt, PhD	Dr. Hoyt has received personal compensation for serving as an employee of Eli Lilly and Co.. Dr. Hoyt has stock in Eli Lilly and Co..
Agnieszka Burzynska	No disclosure on file
Julian Fletcher	No disclosure on file
Federica Matrone	No disclosure on file
Amol Raisingani	Amol Raisingani has nothing to disclose.
Shima Zargar, MD	Dr. Zargar has nothing to disclose.
Andreas Meier, MD	Dr. Meier has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Meier has received personal compensation for serving as an employee of Voyager Therapeutics. Dr. Meier has stock in Vigil Neuroscience. Dr. Meier has stock in Voyager Therapeutics.
Mario Ortega, PhD	Dr. Ortega has received personal compensation for serving as an employee of Teva Pharmaceuticals.